Sandra B Gabelli

33PUBLICATIONS
121CO-AUTHORS
Pharmaceutical delivery technologiesBiologically active moleculesGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 11, 2026
Allosteric Crosstalk between Inhibitor Binding Sites Drives Enhanced Islatravir Susceptibility in F227C HIV-1 Reverse Transcriptase.

|May 26, 2026
The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyond.

|Jan 03, 2026
WRN structural flexibility showcased through fragment-based lead discovery of inhibitors.

Rachel L Palte, Mihir Mandal, Justyna Sikorska

|Dec 31, 2025
Structural Characterization of Linker Shielding in ADC Site-Specific Conjugates.

Maru Jaime-Garza, Andrew Waight, Manish Hudlikar

|Jul 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

Brian J Mog, Nikita Marcou, Sarah R DiNapoli

|May 13, 2024
Cancer therapy with antibodies.

Suman Paul, Maximilian F Konig, Drew M Pardoll

Pageof 6

Frequent Collaborators

9 joint publications

Shibin Zhou

9 joint publications

Suman Paul

9 joint publications

Maximilian F Konig

8 joint publications

Nickolas Papadopoulos